Advertisement

Topics

Companies Related to "Comparative Bioavailability Study of Two Prototypes of Trazodone Controlled-release Products and Two Marketed Reference Products in Healthy Volunteers" [Most Relevant Company Matches] RSS

21:57 EDT 22nd May 2018 | BioPortfolio

Here are the most relevant search results for "Comparative Bioavailability Study of Two Prototypes of Trazodone Controlled-release Products and Two Marketed Reference Products in Healthy Volunteers" found in our extensive corporate database of over 50,000 company records.

Showing "Comparative Bioavailability Study Prototypes Trazodone Controlled release Products" Companies 1–25 of 6,300+

Relevant

Supernus Pharmaceuticals, Inc

Headquartered in Rockville, MD, Supernus Pharmaceuticals, Inc. (formerly Shire Laboratories) is a specialty pharmaceuticals company that has a broad portfolio of proven and patented drug delivery technologies. Among its key technologies are ProScreen® and OptiScreen® for lead selection and formulation optimization, Microtrol®, Solutrol® and EnSoTrol®, its oral controlled release technologies,...


Synovics Pharmaceuticals

Synovics is a specialty pharmaceutical company engaged in the development, manufacturing and commercialization of oral controlled-release generic drugs and improved formulations of previously approved drugs. The Company has licensed exclusive and worldwide rights to employ certain proprietary oral controlled-release drug formulation technologies. Synovics is undertaking the initiation of US develo...

Elite Pharmaceuticals, Inc

Elite Pharmaceuticals is a specialty pharmaceutical company principally engaged in the development and manufacturing of oral controlled-release products. The Company's strategy includes developing generic versions of controlled release drug products with high barriers to entry and assisting partner companies in the life cycle management of products to improve off-patent drug products. Elite's tech...


Flamel Technologies, S.A.

Flamel Technologies, S.A. is a biopharmaceutical company principally engaged in the development of two unique polymer-based delivery technologies for medical applications. Flamel's Medusa technology is designed to deliver controlled-release formulations of therapeutic proteins and peptides and other molecules, without reduction in bioactivity. MicropumpÂ...

ACTIPAC Biosystems GmbH

ACTIPAC is offering a novel technology of advanced nano- and micro-encapsulation of sensitive, highly active drugs. Its main focus is the development of controlled release formulations (sustained release).

Elite

Elite is focused solely on the development of oral controlled release products. Our staff has expertise in: biopharmaceuticals, pharmacokinetics, formulation and processing, analytic techniques such as automated in vitro release testing, HPLC analysis and in vivo evaluations; scale-up and production. Elite can offer major pharmaceutical companies a commitment to quality along with a wide range of ...

Controlled Release Society

Funetics

Funetics provides the neuroscience community with advanced customized technical solutions for their researchNeuroscience laboratories around the world are constantly developing custom software and hardware technology. Funetics helps laboratories to turn these prototypes into products that can be marketed to the Neuroscience community. Funetics invites anyone to submit their prototypes for further ...

Flamel Technologies S.A.

Flamel Technologies is a drug delivery company with two intellectual property platforms: Micropump, for the controlled release of drugs best absorbed in the small intestine; and Medusa, for the controlled release of proteins, peptides, and other molecules injected subcutaneously or administered intravenously. Both of these platforms offer potential advanta...

HµREL Corporation

HµREL Corporation is a development-stage enterprise based in Beverly Hills, California. HµREL’s development is proceeding under the aegis of Athena Capital Partners, LLC, a Los Angeles enterprise sponsorship firm (www.athenacapital.net). HµREL is presently inaugurating a Joint Scientific Collaboration (“JSC”), through which a group of global pharmaceutical and consumer products firms will...

Neos Therapeutics, Inc.

Neos Therapeutics Inc. is a specialty pharmaceutical company focused on the development, manufacture and sale of FDA approved drug products which utilize the Company’s proprietary delivery technologies. Neos’ drug products are being developed using the Dynamic Time Release Suspension® (DTRS®) and Rapidly Disintegrating Ionic Masking™ (RDIMâ...

BioGuard Technologies, Inc

BioGuard Technologies develops, licenses and manufactures safe, environmentally friendly sustained-release delivery systems for agrochemicals and biological control agents.Our technology solves some of the most significant issues in the pest control industry. BioGuard's controlled release technology allows you to release or deliver pesticide exactly where and when it's needed. Because it delivers ...

DelSiTech Ltd

Founded in 2001, DelSiTech Ltd is located in Turku Science Park in Turku, Finland.The company operates in the development and licensing of long-term controlled drug delivery implant, subcutaneous or intramuscular formulations.The unique controlled release DelSiTech™ technology based on amorphous silica is flexible and applicable for synthetic small molecules but especially for labile biopharmace...

GP Pharm

Gp pharm is a pharmaceutical company within the Lipotec Group whose foundation dates back from 2001. The company is undertaking the pharmaceutical and the clinical development of the new products containing hormones and cytotoxic drugs. Some of these products are controlled release dosage forms developed and patented by the Drug Delivery research team.

Cytokine PharmaSciences, Inc.

Cytokine PharmaSciences, Inc. (CPSI), is a privately held, global biopharmaceutical company developing (i) controlled-release drug delivery products, primarily in the area of women’s health, and (ii) small molecule therapeutics in the areas of autoimmune diseases, inflammation and cancer. In addition to manufacturing a best-selling obstetric product currently on the market worldwide, the Compan...

Egalet a/s

Egalet a/s is focused on the development of innovative pharmaceutical products utilizing the Company’s proprietary, erosion-based, controlled-release technology, Egalet®, and a novel formulation system, Parvulet®, aimed at the pediatric market. Egalet’s product pipeline currently has four products in clinical development, two of which are entering late-stage pivotal studies in the cardiovasc...

Eurand

Eurand is a specialty pharmaceutical company that develops enhanced pharmaceutical and biopharmaceutical products using our innovative drug delivery technologies. The Company’s drug development efforts are based on three commercialized technology platforms; bioavailability enhancement of poorly soluble drugs, customized release and taste masked/fast dissolving formulations. Eurand has recently a...

Labopharm

We are an emerging leader in optimizing the performance of existing small molecule drugs using our proprietary controlled-release technologies. Our lead product, a unique once-daily formulation of tramadol, is being commercially launched in key markets globally and we have a robust pipeline of follow-on products in both pre-clinical and clinical development. Our vision is to become a fully integra...

Handa Pharmaceuticals, LLC

Handa Pharmaceuticals, LLC is a specialty pharmaceutical company that was established in the San Francisco Bay area in November 2005. Handa's executive leadership has a proven track record of developing controlled-release prescription pharmaceutical products that are difficult to formulate. For more information, please visit http://www.handapharma.com.

Cytokine PharmaSciences, Inc

Cytokine PharmaSciences, Inc., is a privately held, global biopharmaceutical company developing (i) controlled-release drug delivery products, primarily in the area of women’s health, and (ii) small molecule therapeutics in the areas of autoimmune diseases, anti-inflammation and cancer.In addition to manufacturing a best-selling obstetric product currently on the market worldwide, the Company ha...

Adeona Pharmaceuticals, Inc.

Adeona (AMEX: AEN) is a pharmaceutical company developing new medicines for serious central nervous systems diseases. Adeona's primary strategy is to in-license clinical-stage drug candidates that have already demonstrated a certain level of clinical efficacy and develop them to an inflection point in valuation resulting in a significant development and marketing collaboration. Trimesta (estriol) ...

Improved Outcomes Software

Welcome to Improved Outcomes SoftwareImproved Outcomes Software (IOS) is pleased to announce the release of GeneLinker(TM) Gold and Platinum 4.6, new versions of the award-winning Gene Expression and Proteomics Analysis Software products. See the full press release for more details. This is also the first release of GeneLinker by Improved Outcomes Software Inc. (following Predictive Patterns Softw...

Emilio Castelli

The company was founded in 1951; over more than 30 years Emilio Castelli SAS has built its expertise in Neutral Pellets = Sugar Spheres, for the pharmaceutical industry. "Sugar Spheres" are solid drug excipients for sustained and controlled release pharmaceutical products."In contrast to granulates the pellets have nearly ideal spherical form. Their development is connected with the hard gelatine ...

Durect

DURECT Corporation is an emerging specialty pharmaceutical company focused on the development of pharmaceutical systems based on its proprietary drug delivery platform technologies to treat chronic debilitating diseases and enable biotechnology products. These platform technologies include the SABER™ Delivery System (a patented and versatile depot injectable useful for proteins, peptides and sma...

OcuMedic, Inc.

OcuMedic, Inc. is the developer of the world’s first, drug-eluting therapeutic lens/clear corneal bandage for the delivery of drugs for the global ophthalmic market. Invented by Mark Byrne, Ph.D. distinguished engineering professor and Head of the Department of Biomedical Engineering at Rowan University, the therapeutics lens is a soft contact develop...


More From BioPortfolio on "Comparative Bioavailability Study of Two Prototypes of Trazodone Controlled-release Products and Two Marketed Reference Products in Healthy Volunteers"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks